Rivaroxaban and Risk of VTE in Patients With Symptomatic PAD After Lower-Extremity Revascularization
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization
JAMA Netw Open 2022 Jun 01;5(6)e2215580, CN Hess, M Szarek, SS Anand, RM Bauersachs, MR Patel, ES Debus, MR Nehler, WH Capell, JA Beckman, G Piazza, S Henkin, A Bura-Rivière, H Lawall, K Roztocil, J Hsia, E Muehlhofer, SD Berkowitz, LP Haskell, MP BonacaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.